Experimental oncology

Biliopancreatic endoscopy and endoscopic ultrasonography


Head physician

Paolo Giorgio Arcidiacono


The Unit of bilio-pancreatic endoscopy and diagnostic and operative endoscopic ultrasonography has two major clinical and research expertise areas:

  • Diagnostic and Operative Endoscopic Ultrasonography
  • Pancreato-biliary Endoscopy

Currently, the unit represents the largest in Italy as a reference for the procedures of Diagnostic and Operative Endoscopic Ultrasonography and therapeutic ERCP. Moreover, it is a reference point for both the Italian and international advanced teaching activities for the study and the different clinical applications of Endoscopic Ultrasonography and ERCP, being certified Center for the International University Master's Degree in both the Diagnostic and Operative Endoscopic Ultrasonography and the therapeutic ERCP, that lasts one academic year and is aimed to Italian and foreign specialists in Gastroenterology.

The unit organizes advanced "hands on" training in the various specialties, addressed to both Italian and foreign specialists, and congress, meetings and courses accredited for CME formations.

Research activity

The Pancreatico-Biliary Endoscopy Unit represents one of the major Italian centers due to the number of examinations and the scientific activities, whose research fields develop in the treatment of both the pancreatic-biliary malignancy and the inflammatory diseases.

Main research fields are:

  • Acute pancreatitis
  • Pancreatic neoplasia
  • Biliary ducts benign and malignant tumors

The Diagnostic and Operative Endosonography Unit is the largest Italian and one of the largest European Center, due to the number of procedures and the research activities. The research fields in which the Center carries out most of its activity, with collaborations at National and International level, are:

  • Diagnostic and staging of pancreatic neoplasia
  • Endosonography-guided local ablative therapy of solid pancreatic lesions
  • Register and screening of familiar pancreatic cancer